首页|潮州地区乙肝病毒分型和耐药突变基因检测的应用

潮州地区乙肝病毒分型和耐药突变基因检测的应用

扫码查看
目的 探讨潮州地区乙型肝炎病毒(HBV)基因分型和耐药基因突变检测的临床意义.方法 采用PCR-反向点杂交(RDB)法对慢性乙肝(Chronic hepatitis B,CHB)患者血清进行基因分型和耐药突变检测,拉米夫定(Lamivudine)耐药患者改用阿德福韦酯(Adefovir)治疗,1 a后测定其HBV DNA和谷丙转氨酶(ALT)含量.结果 HBV B亚型占92.31%(120/130),HBV C亚型占5.38%(7/130),B+D基因型占3.21%(3/130).检测出24例均为HBV B亚型的耐药突变基因,耐药突变率18.46%(24/130).HBV B亚型与HBVC亚型的HBV DNA和ALT含量比较差异有统计学意义(P<0.05),阿德福韦酯治疗1 a前后的HBV DNA和ALT含量差异有统计学意义(P<0.05).结论 潮州地区HBV基因型以B亚型为主,耐药突变基因型是影响疾病进程的重要因素.
Application of hepatitis B virus genotyping and drug-resistance mutation genes detecting in Chaozhou area
Objective To evaluate the clinical significance of hepatitis B virus genotype and drug resistance genes mutation detection in Chaozhou. Methods The PCR-RDB was used to detect hepatitis B virus genotypes and drug resistance genes mutations in CHB patients. Adefovir was selected to therapy the patients with Lamivudine resistance gene mutations, the HBV DNA load and ALT content were detected again one year later. Results The infection rate of HBV B,C and B+D were 92. 31% (120/130) ,5. 38%(7/130) ,3. 21% (3/130) respectively. Lamivudine resistance mutation genes were detected in 24 persons,who were all HBV B genotype infectors. The rate of drug-resistance mutation was 18. 46% (24/130). Significant differences were found between the HBV B and the HBV C infectors when their HBV DNA load and ALT content were compared. Moreover, the HBV DNA load and ALT content of the Adefovir receptor were significantly decreased than one year ago. Conclusions HBV B is the most common HBV genotype in Chaozhou. Drug-resistance genes mutation is one of key factor that influence the CHB development.

Hepatitis B virusgeneticsDrug Tolerancegenetics

陈立华、黄泽伟、罗招云、林芬、林春萍

展开 >

广东省潮州市中心医院检验实验中心 521021

肝炎病毒,乙型/遗传学 药物耐受性/遗传学

广东省医学科学研究基金广东省医学科学研究基金

A2011760B2008179

2012

中国误诊学杂志
中华预防医学会 漯河市中心医院 重庆第九人民医院

中国误诊学杂志

影响因子:0.406
ISSN:1009-6647
年,卷(期):2012.12(14)
  • 2
  • 5